Last update 28 Jun 2025

HS-10501

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HS-10501
Target
GLP-1R
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
ObesityDiabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Jiangsu Hansoh Pharmaceutical Co., Ltd.Jiangsu Hansoh Pharmaceutical Co., Ltd.
Active Organization
Jiangsu Hansoh Pharmaceutical Co., Ltd.Jiangsu Hansoh Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with HS-10501
CTR20251769
/ RecruitingPhase 2
在超重和肥胖受试者中评估每天一次口服HS-10501/HS-10501-2的有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate the efficacy and safety of once-daily oral HS-10501/HS-10501-2 in overweight and obese subjects
ChiCTR2400081640
/ RecruitingPhase 1IIT
Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10501 Tablets after Single and Multiple Oral Administration in Healthy Subjects
NCT06359600
/ RecruitingPhase 1
A Randomized, Double-blind, Placebo-controlled, Dose Escalation Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10501 Tablets After Single and Multiple Oral Doses in Healthy Subjects
100 Clinical Results associated with HS-10501
Login to view more data
100 Translational Medicine associated with HS-10501
Login to view more data
100 Patents (Medical) associated with HS-10501
Login to view more data
100 Deals associated with HS-10501
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPhase 2
China
Jiangsu Hansoh Pharmaceutical Co., Ltd.Jiangsu Hansoh Pharmaceutical Co., Ltd.
28 May 2025
Diabetes Mellitus, Type 2Phase 1
China
Jiangsu Hansoh Pharmaceutical Co., Ltd.Jiangsu Hansoh Pharmaceutical Co., Ltd.
14 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free